Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;28(1):67-73.
doi: 10.3346/jkms.2013.28.1.67. Epub 2013 Jan 8.

Trends of mortality and cause of death among HIV-infected patients in Korea, 1990-2011

Affiliations

Trends of mortality and cause of death among HIV-infected patients in Korea, 1990-2011

Sun Hee Lee et al. J Korean Med Sci. 2013 Jan.

Abstract

Although a decrease in acquired immunodeficiency syndrome (AIDS)-related mortality has been documented in highly active antiretroviral therapy (HAART) era, there are no published data comparing specific causes of death between pre-HAART and HAART era in Korea. Mortality and cause of death were analyzed in three treatment periods; pre-HAART (1990-1997), early-HAART (1998-2001), and late-HAART period (2002-2011). The patients were retrospectively classified according to the treatment period in which they were recruited. Although mortality rate per 100 person-year declined from 8.7 in pre-HAART to 4.9 in late-HAART period, the proportion of deaths within 3 months of initial visit to study hospital significantly increased from 15.9% in pre-HAART to 55.1% in late-HAART period (P < 0.001). Overall, 59% of deaths were attributable to AIDS-related conditions, and Pneumocystis pneumonia (PCP) was the most common cause of death (20.3%). The proportion of PCP as cause of death significantly increased from 8.7% in pre-HAART to 31.8% in late-HAART period (P < 0.001). Despite of significant improvement of survival, there was still a high risk of early death in patients presenting in HAART era, mainly due to late human immunodeficiency virus (HIV) diagnosis and late presentation to care.

Keywords: Antiretroviral Therapy; Cause of Death; HIV; Mortality.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Kaplan-Meier survival plot for HIV-infected patients stratified by the treatment period in which they were recruited. Pre-HAART period (1990-1997), early-HAART period (1998-2001), and late-HAART period (2002-2011) (Generalized Wilcoxon test, χ2 test value of 28.8 on 2 degree of freedom, unadjusted P < 0.001 for comparisons among each period).

Similar articles

Cited by

References

    1. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, Knysz B, Dietrich M, Phillips AN, Lundgren JD. Decline in the AIDS and death rates in the EUROSIDA study: an observational study. Lancet. 2003;362:22–29. - PubMed
    1. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d'Arminio Monforte A, Yust I, Bruun JN, Phillips AN, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EUROSIDA study group. Lancet. 1998;352:1725–1730. - PubMed
    1. Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860. - PubMed
    1. Aldaz P, Moreno-Iribas C, Egues N, Irisarri F, Floristan Y, Sola-Boneta J, Martinez-Artola V, Sagredo M, Castilla J. Mortality by causes in HIV-infected adults: comparison with the general population. BMC Public Health. 2011;11:300. - PMC - PubMed
    1. Jaggy C, von Overbeck J, Ledergerber B, Schwarz C, Egger M, Rickenbach M, Furrer HJ, Telenti A, Battegay M, Flepp M, et al. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet. 2003;362:877–878. - PubMed

Publication types